{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:22:46Z","timestamp":1791235366460,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Dalian Science and Technology Innovation Funds","award":["2020JJ27SN096"],"award-info":[{"award-number":["2020JJ27SN096"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"DOI":"10.1186\/s13000-024-01584-0","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T06:59:21Z","timestamp":1734677961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prognostic factors and survival outcomes of immunohistochemically detection based-molecular subtypes of endometrial cancer\u2013analysis of 576 clinical cases"],"prefix":"10.1186","volume":"19","author":[{"given":"Xiaohui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziz ur Rehman","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,20]]},"reference":[{"key":"1584_CR1","doi-asserted-by":"crossref","unstructured":"Miller, K.D., et al., Cancer treatment and survivorship statistics, 2022. CA: a cancer journal for clinicians. 2022;72(5):a409\u2013436.","DOI":"10.3322\/caac.21731"},{"key":"1584_CR2","doi-asserted-by":"crossref","unstructured":"Levine, D.A., et al., Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497(7447):a67\u201373.","DOI":"10.1038\/nature12113"},{"key":"1584_CR3","unstructured":"Le\u00f3n-Castillo, A., et al., Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy. J Clin Oncol. 2020;38(29):a3388\u20133397."},{"key":"1584_CR4","doi-asserted-by":"crossref","unstructured":"Fremond, S., et al., The evolving role of morphology in endometrial cancer diagnostics: From histopathology and molecular testing towards integrative data analysis by deep learning. Front Oncol. 2022;12:a928977.","DOI":"10.3389\/fonc.2022.928977"},{"key":"1584_CR5","doi-asserted-by":"crossref","unstructured":"Colombo, N., et al., ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up. Ann Oncol. 2016;27(1):a16\u201341.","DOI":"10.1097\/IGC.0000000000000609"},{"key":"1584_CR6","doi-asserted-by":"crossref","unstructured":"Concin, N., et al., ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma. Virchows Archiv. 2021;478:a153\u2013190.","DOI":"10.1007\/s00428-020-03007-z"},{"key":"1584_CR7","doi-asserted-by":"crossref","unstructured":"Talhouk, A., et al., A clinically applicable molecular-based classification for endometrial cancers. British journal of cancer. 2015;113(2):a299\u2013310.","DOI":"10.1038\/bjc.2015.190"},{"key":"1584_CR8","doi-asserted-by":"crossref","unstructured":"Raffone, A., et al., Diagnostic accuracy of immunohistochemistry for mismatch repair proteins as surrogate of microsatellite instability molecular testing in endometrial cancer. Pathology & Oncology Research. 2020;26:a1417\u20131427.","DOI":"10.1007\/s12253-020-00811-5"},{"key":"1584_CR9","doi-asserted-by":"crossref","unstructured":"Raffone, A., et al., Diagnostic accuracy of p53 immunohistochemistry as surrogate of TP53 sequencing in endometrial cancer. Pathology-Research and Practice. 2020;216(8):a153025.","DOI":"10.1016\/j.prp.2020.153025"},{"key":"1584_CR10","doi-asserted-by":"crossref","unstructured":"Imboden, S., et al., Implementation of the 2021 molecular ESGO\/ESTRO\/ESP risk groups in endometrial cancer. Gynecologic oncology. 2021;162(2):a394\u2013400.","DOI":"10.1016\/j.ygyno.2021.05.026"},{"key":"1584_CR11","doi-asserted-by":"crossref","unstructured":"Loukovaara, M., A. Pasanen, and R. B\u00fctzow, Clinicopathologic vs. molecular integrated prognostication of endometrial carcinoma by European guidelines. Cancers. 2022;14(3):a651.","DOI":"10.3390\/cancers14030651"},{"key":"1584_CR12","unstructured":"Wen Hao, H.W., The Chinese Expert Consensus Recommendations on Molecular Testing in Endometrial Cancer (2021 Edition). China oncology. 2021;31(11):a1126\u20131144."},{"key":"1584_CR13","doi-asserted-by":"crossref","unstructured":"K\u00f6bel, M., et al., Interpretation of P53 immunohistochemistry in endometrial carcinomas: toward increased reproducibility. International journal of gynecological pathology. 2019;38(1 Suppl 1):aS123.","DOI":"10.1097\/PGP.0000000000000488"},{"key":"1584_CR14","doi-asserted-by":"crossref","unstructured":"Kommoss, S., et al., Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series. Ann Oncol. 2018;29(5):a1180\u20131188.","DOI":"10.1093\/annonc\/mdy058"},{"key":"1584_CR15","doi-asserted-by":"crossref","unstructured":"Bray, F., et al., Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2018;68(6):a394\u2013424.","DOI":"10.3322\/caac.21492"},{"key":"1584_CR16","doi-asserted-by":"crossref","unstructured":"Renehan, A.G., et al., Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. The lancet. 2008;371(9612):a569\u2013578.","DOI":"10.1016\/S0140-6736(08)60269-X"},{"key":"1584_CR17","doi-asserted-by":"crossref","unstructured":"Raffone, A., et al., Histopathological characterization of ProMisE molecular groups of endometrial cancer. Gynecologic oncology. 2020;157(1):a252\u2013259.","DOI":"10.1016\/j.ygyno.2020.01.008"},{"key":"1584_CR18","doi-asserted-by":"crossref","unstructured":"Donato, V.D., et al. Impact of Hormone Receptor Status and Ki-67 Expression on Disease-Free Survival in Patients Affected by High-risk Endometrial Cancer. International Journal of Gynecological Cancer. 2018;28:505\u2013513.","DOI":"10.1097\/IGC.0000000000001191"},{"key":"1584_CR19","doi-asserted-by":"crossref","unstructured":"van der Putten, L.J.M., et al., Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study. International Journal of Gynecologic Cancer. 2018;28(3):a514\u2013523.","DOI":"10.1097\/IGC.0000000000001187"},{"key":"1584_CR20","doi-asserted-by":"crossref","unstructured":"Perrone, E., et al., Back to the future: The impact of oestrogen receptor profile in the era of molecular endometrial cancer classification. European Journal of Cancer. 2023;186:a98\u2013112.","DOI":"10.1016\/j.ejca.2023.03.016"},{"key":"1584_CR21","doi-asserted-by":"crossref","unstructured":"Vrede, S.W., et al., Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer. Gynecol Oncol. 2021;161(3):a787\u2013794.","DOI":"10.1016\/j.ygyno.2021.03.031"},{"key":"1584_CR22","doi-asserted-by":"crossref","unstructured":"Trovik, J., et al., Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial. Eur J Cancer. 2013;49(16):a3431-41.","DOI":"10.1016\/j.ejca.2013.06.016"},{"key":"1584_CR23","doi-asserted-by":"crossref","unstructured":"Lawes, D., S. SenGupta, andaBoulos, The clinical importance and prognostic implications of microsatellite instability in sporadic cancer. European Journal of Surgical Oncology (EJSO). 2003;29(3):a201\u2013212.","DOI":"10.1053\/ejso.2002.1399"},{"key":"1584_CR24","doi-asserted-by":"crossref","unstructured":"McMeekin, D.S., et al., Clinicopathologic significance of mismatch repair defects in endometrial cancer: an NRG oncology\/gynecologic oncology group study. Journal of Clinical Oncology. 2016;34(25):a3062.","DOI":"10.1200\/JCO.2016.67.8722"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-024-01584-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-024-01584-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-024-01584-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T07:05:36Z","timestamp":1734678336000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-024-01584-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,20]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1584"],"URL":"https:\/\/doi.org\/10.1186\/s13000-024-01584-0","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,20]]},"assertion":[{"value":"5 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"162"}}